Bright Minds Biosciences Shares to Commence Trading on the OTCQB Venture Market on May 17, 2021

May 17, 2021

Ocugen Provides Business Update with First Quarter 2025 Financial Results

May 9, 2025
Alzamend Neuro Partners with QMENTA, to Advance AI-Powered Imaging for its Phase II Clinical Trial of AL001 Study to Take Place at Massachusetts General Hospital

May 7, 2025
OS Therapies Announces Issuance of U.S. Patent #12,239,738 Protecting Commercial Manufacturing Market Exclusivity for OST-HER2 in Rare Pediatric Cancer Osteosarcoma and Full Listeria Cancer Immunotherapy Platform into 2040

May 7, 2025
Pacaso — The $1.3 Trillion Secret That Everyday Investors Are Finally Invited To

May 6, 2025